Literature DB >> 9252409

Chromogranin A fragments modulate cell adhesion. Identification and characterization of a pro-adhesive domain.

A Gasparri1, A Sidoli, L P Sanchez, R Longhi, A G Siccardi, P C Marchisio, A Corti.   

Abstract

Although several functions have been suggested for chromogranin A, a glycoprotein secreted by many neuroendocrine cells, the physiological role of this protein and of its proteolytic fragments has not been established. We have found that mixtures of chromogranin A fragments can inhibit fibroblast adhesion. The anti-adhesive activity was converted into pro-adhesive activity by limited trypsin treatment. Pro-adhesive effects were observed also with recombinant N-terminal fragments corresponding to residues 1-78 and 1-115 and with a synthetic peptide encompassing the residues 7-57. These fragments induced adhesion and spreading of fibroblasts on plates coated with collagen I or IV, laminin, fetal calf serum (FCS) but not on bovine serum albumin. The long incubation time required for adhesion assays (4 h) and the FCS requirements for optimal adhesion suggest that the adhesive activity is likely indirect and requires other proteins present in the FCS or made by the cells. These findings suggest that chromogranin A and its fragments could play a role in the regulation of cell adhesion. Since chromogranin A is concentrated and stored within granules and rapidly released by neuroendocrine cells and neurons after an appropriate stimulus, this protein could be important for the local control of cell adhesion by stimulated cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9252409     DOI: 10.1074/jbc.272.33.20835

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  The N-terminal fragment of chromogranin A, vasostatin-1 protects mice from acute or chronic colitis upon oral administration.

Authors:  Cristiano Rumio; Giuseppina F Dusio; Barbara Colombo; Anna Gasparri; Diego Cardani; Fabrizio Marcucci; Angelo Corti
Journal:  Dig Dis Sci       Date:  2012-01-26       Impact factor: 3.199

2.  Role of vasostatin-1 C-terminal region in fibroblast cell adhesion.

Authors:  Eleonora Dondossola; Anna Gasparri; Angela Bachi; Renato Longhi; Marie-Hélène Metz-Boutigue; Bruno Tota; Karen B Helle; Flavio Curnis; Angelo Corti
Journal:  Cell Mol Life Sci       Date:  2010-03-09       Impact factor: 9.261

3.  Chromogranin A binds to αvβ6-integrin and promotes wound healing in mice.

Authors:  Flavio Curnis; Anna Maria Gasparri; Renato Longhi; Barbara Colombo; Silvia D'Alessio; Fabio Pastorino; Mirco Ponzoni; Angelo Corti
Journal:  Cell Mol Life Sci       Date:  2012-03-14       Impact factor: 9.261

Review 4.  Chromogranin A and the tumor microenvironment.

Authors:  Angelo Corti
Journal:  Cell Mol Neurobiol       Date:  2010-11-16       Impact factor: 5.046

5.  Plasma and tissue chromogranin in patients with adrenocortical adenomas.

Authors:  G P Bernini; A Moretti; M Borgioli; M Bardini; P Miccoli; P Berti; F Basolo; P Faviana; R Birindelli; A Salvetti
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

6.  Chromogranin a processing in human pituitary adenomas and carcinomas: analysis with region-specific antibodies.

Authors:  Long Jin; Shuya Zhang; Jill Bayliss; Bernd Scheithauer; Xiang Qian; Ikuo Kobayashi; Mats Stridsberg; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

7.  A novel bioengineered fragment peptide of Vasostatin-1 exerts smooth muscle pharmacological activities and anti-angiogenic effects via blocking VEGFR signalling pathway.

Authors:  Ran Wei; Qiushuang Wu; Nana Ai; Lei Wang; Mei Zhou; Chris Shaw; Tianbao Chen; Richard Dequan Ye; Wei Ge; Shirley W I Siu; Hang Fai Kwok
Journal:  Comput Struct Biotechnol J       Date:  2021-05-03       Impact factor: 7.271

8.  Two chromogranin a-derived peptides induce calcium entry in human neutrophils by calmodulin-regulated calcium independent phospholipase A2.

Authors:  Dan Zhang; Peiman Shooshtarizadeh; Benoît-Joseph Laventie; Didier André Colin; Jean-François Chich; Jasmina Vidic; Jean de Barry; Sylvette Chasserot-Golaz; François Delalande; Alain Van Dorsselaer; Francis Schneider; Karen Helle; Dominique Aunis; Gilles Prévost; Marie-Hélène Metz-Boutigue
Journal:  PLoS One       Date:  2009-02-19       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.